Constellation Energy is preparing to restart what's now called the Crane Clean Energy Center on Three Mile Island to supply ...

About 1 in 6 women were found to experience symptoms of postpartum depression 2 months after cesarean delivery.

In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

Controller medications, also known as daily maintenance medications, are a critical tool for managing asthma — reducing daily ...

Bell reported relationships with the Dementia Australia Research Foundation, GlaxoSmithKline Supported Studies Programme, ...

A Birmingham-based advertising and marketing agency has tapped a new C-suite leader. Mark Unrein is the new chief AI officer for Luckie & Co. He will split his time between the company's Birmingham ...

Health Canada has granted approval for GlaxoSmithKline’s (GSK) Ojjaara (momelotinib) for treating myelofibrosis (MF) in ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares closed yesterday at ...

GlaxoSmithKline Pharmaceuticals on Tuesday reported a 16 per cent year-on-year increase in its consolidated net profit to Rs 252 crore in the September quarter, aided by robust sales across segments.

Multiple sclerosis (MS) is a chronic neurological disorder affecting the central nervous system (CNS), particularly the brain, spinal cord, and optic nerves. Continuous research has led to new drug ...